Physician profile
Prasad J Thottam
NPI 1851720312
$43,443.47
in general payments reported to CMS, 2019-2025
13 companies · $6,813 in 2025
The $6,813 reported for 2025 was more than what 96% of Otolaryngology/Facial Plastic Surgery providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $832 · 2020: $15.10 · 2021: $528 · 2022: $354 · 2023: $15K · 2024: $20K · 2025: $6,813.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $40K · Food and Beverage: $1,690.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $40,025.00 |
| Food and Beverage | $1,690.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $22,982.85 | 2024-2025 | Acclarent Aera, Relieva Spinplus Nav, Integra |
| Acclarent, INC | $18,394.18 | 2019-2024 | Acclarent Balloon Inflation Device, Acclarent Aera, Acclarent Navwire |
| Medtronic, INC. | $598.86 | 2021-2025 | Propel, Stealthstation S8 Platform |
| Intersect Ent, INC. | $407.35 | 2019-2021 | |
| Stryker Corporation | $273.87 | 2019-2024 | Xpress Loprofile |
| Glaxosmithkline, LLC. | $221.69 | 2021-2022 | |
| Becton, Dickinson and Company | $142.99 | 2019 | |
| Sanara Medtech INC. | $127.98 | 2024 | Celleraterx |
| Ars Pharmaceuticals Operations, INC. | $120.04 | 2025 | Neffy |
| Optinose US, INC. | $116.07 | 2019 | |
| Novartis Pharmaceuticals Corporation | $28.47 | 2019 | |
| Smith+Nephew, INC. | $15.10 | 2020 | |
| Dexcom, INC. | $14.02 | 2023 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prasad Thottam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.